illumina oncoarray 500k beadchip (Illumina Inc)
Illumina Inc is a verified supplier 
93
Structured Review
Illumina Inc
illumina oncoarray 500k beadchip
Illumina Oncoarray 500k Beadchip, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 93/100, based on 54 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/illumina+oncoarray+500k+beadchip/Infinium+OncoArray-500K+BeadChip+Kit/pm42895956-83-8-8
Average 93 stars, based on 54 article reviews
Illumina Oncoarray 500k Beadchip, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 93/100, based on 54 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/illumina+oncoarray+500k+beadchip/Infinium+OncoArray-500K+BeadChip+Kit/pm42895956-83-8-8
Average 93 stars, based on 54 article reviews
illumina oncoarray 500k beadchip - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
other:Article Title: Assessment of prostate cancer polygenic risk score in a community-based pilot study. Article Snippet: The extracted DNA samples were genotyped using the Article Title: Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer Article Snippet: Genotypes were established as part of the Collaborative Oncological Gene-Environment Study (COGS) and the OncoArray project using the Article Title: Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer. Article Snippet: PreFace samples: Genotypingwas also established as part of the OncoArray project using the Article Title: Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer Article Snippet: PreFace samples: Genotyping was also established as part of the OncoArray project using the Article Title: Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification Article Snippet: Genotyping was performed on the Article Title: Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer. Article Snippet: Genotypes were established as part of the Collaborative Oncological Gene-Environment Study (COGS) and the OncoArray project using the Control:Article Title: TLR4 Downregulation Protects Against Cisplatin-Induced Ototoxicity in Adult and Pediatric Cancer Patients Article Snippet: .. Patient genotyping was initially conducted using the |